Silvercrest Asset Management’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Hold |
103,500
| – | – | ﹤0.01% | 737 |
|
|
2025
Q1 | $518K | Hold |
103,500
| – | – | ﹤0.01% | 695 |
|
|
2024
Q4 | $746K | Hold |
103,500
| – | – | 0.01% | 634 |
|
|
2024
Q3 | $635K | Hold |
103,500
| – | – | ﹤0.01% | 623 |
|
|
2024
Q2 | $688K | Hold |
103,500
| – | – | ﹤0.01% | 669 |
|
|
2024
Q1 | $1.05M | Hold |
103,500
| – | – | 0.01% | 604 |
|
|
2023
Q4 | $1.16M | Hold |
103,500
| – | – | 0.01% | 564 |
|
|
2023
Q3 | $269K | Hold |
103,500
| – | – | ﹤0.01% | 763 |
|
|
2023
Q2 | $365K | Hold |
103,500
| – | – | ﹤0.01% | 719 |
|
|
2023
Q1 | $437K | Buy |
103,500
+41,000
| +66% | +$173K | ﹤0.01% | 670 |
|
|
2022
Q4 | $1.03M | Hold |
62,500
| – | – | 0.01% | 575 |
|
|
2022
Q3 | $798K | Hold |
62,500
| – | – | 0.01% | 585 |
|
|
2022
Q2 | $731K | Hold |
62,500
| – | – | 0.01% | 603 |
|
|
2022
Q1 | $381K | Buy |
+62,500
| New | +$381K | ﹤0.01% | 727 |
|